House Passes Five-Month Extension Of Fentanyl Analogue Scheduling

By Maya Goldman / April 21, 2021 at 7:09 PM
The House passed a bill Wednesday (April 21) to authorize a five-month extension on emergency scheduling of fentanyl-like substances, which classifies the analogues as Schedule 1 drugs. The Trump administration’s Drug Enforcement Administration temporarily scheduled fentanyl-related substances as Schedule 1 in 2018, which classifies them as illicit drugs with high potential for abuse and no medical use. The scheduling was extended in 2020 and was set to expire May 6. It would now expire Oct. 22 if the House bill...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.